A Study to Evaluate the Pharmacist Role and Pharmacogenomics in the Care of Seriously Ill Patients
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 18-010761
NCT ID: NCT04251520
Sponsor Protocol Number: 18-010761
About this study
The purposes of this study are to evaluate:
- The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management;
- Patient perceptions, satisfaction and behaviors related to their medications and their view of the helpfulness of the pharmacist,
- The impact that a clinical pharmacist and pharmacogenomic testing has on overall cost of care; and
- The impact that a clinical pharmacist and pharmacogenomic testing has on average cost of medications.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- English speaking.
- Age 18 years and older.
- Palliative Medicine is consulted for the first time in either the outpatient setting for symptom management and plan to continue to follow up with the Palliative Medicine team in the outpatient setting for the foreseeable future.
- Insurance accepted at Mayo Clinic Arizona.
- Live within metro Phoenix area.
Exclusion Criteria:
- Vulnerable adults.
- Under 18 years of age.
- Pregnant patients.
- Non-English speaking patients.
- Patients that lack capacity for medical decision making.
- Patients who live outside the metro Phoenix area.
- Patients who are lost to follow up secondary to enrolling in hospice, die or fail to show or answer surveys within 2 months of enrollment.
- Patients with uncontrolled concurrent illness including psychiatric illness, or situations that would limit compliance with the study requirements or the ability to willingly give written informed consent.
- Patients previously established within the Palliative Medicine Clinic who receive ongoing Palliative Medicine services.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Mark Edwin, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available